Tag: pharmaceuticals
-
FDA Warns Cord Blood-Stem Cell Company
Food and Drug Administration recently warned GeneTech Inc. that its unauthorized stem cell regenerative medicine products, may be causing serious blood infections.
-
Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.
-
A.I.-Aided Processes Reduce Chemical Reaction Time, Waste
A chemical engineering lab designed processes with artificial intelligence to screen chemical reactions in small quantities that can reduce the time and waste in current methods.
-
Companies to Analyze 40,000 Protein Samples
A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples.
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.
-
FDA Clears Mobile App for Opioid Use Disorder
The Food and Drug Administration authorized a mobile app, when prescribed by clinicians for patients with opioid use disorder in outpatient treatment programs.
-
Patent Set for Long-Term Drug Capsules
Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Post-Surgical Opioid Prescriptions Safely Cut
A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills.